Convenient loading dosage of the oral suspension helps reduce dosage frequency Home-grown pharma major, FDC Limited, today, announced the launch of India’s first oral suspension of Favipiravir – Favenza Oral Suspension, used to treat mild to moderate cases of COVID-19. This prescription-only solution is currently available at all retail medical outlets and